Xiong Yun-Xia, Huang Zhi-Shu, Tan Jia-Heng
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Eur J Med Chem. 2015 Jun 5;97:538-51. doi: 10.1016/j.ejmech.2014.11.021. Epub 2014 Nov 12.
G-Quadruplex nucleic acids or G-quadruplexes (G4s) are four-stranded DNA or RNA secondary structures that are formed in guanine-rich sequences. They are widely distributed in functional regions of the human genome, such as telomeres, ribosomal DNA (rDNA), transcription start sites, promoter regions and untranslated regions of mRNA, suggesting that G-quadruplex structures may play a pivotal role in the control of a variety of cellular processes. G-Quadruplexes are viewed as valid therapeutic targets in human cancer diseases. Small molecules, from naturally occurring to synthetic, are exploited to specifically target G-quadruplexes and have proven to be a new class of anticancer agents. Notably, alkaloids are an important source of G-quadruplex ligands and have significant bioactivities in anticancer therapy. In this review, the authors provide a brief, up-to-date summary of heterocyclic alkaloids and their derivatives targeting G-quadruplexes.
G-四链体核酸或G-四链体(G4s)是在富含鸟嘌呤的序列中形成的四链DNA或RNA二级结构。它们广泛分布于人类基因组的功能区域,如端粒、核糖体DNA(rDNA)、转录起始位点、启动子区域和mRNA的非翻译区域,这表明G-四链体结构可能在多种细胞过程的控制中起关键作用。G-四链体被视为人类癌症疾病中有效的治疗靶点。从小分子天然产物到合成分子,都被用于特异性靶向G-四链体,并已被证明是一类新型抗癌药物。值得注意的是,生物碱是G-四链体配体的重要来源,在抗癌治疗中具有显著的生物活性。在这篇综述中,作者简要介绍了靶向G-四链体的杂环生物碱及其衍生物的最新研究进展。